Ramalingam Selvarajah
Adult Medicine · London, OHNPI 1104912773
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 379 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,316 and has fallen 54.2% since, to $603 in 2025. Among adult medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 379 payments — averaging $15.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Amgen$884
- AbbVie$778
- GSK$351
- Astellas Pharma US Inc$342
- Novo Nordisk$297
- plus $2K from 31 others
What the payments were for
- Food & beverage$5,85897%
- Education$1953%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 54 | $1,269 |
| Amgen | 52 | $884 |
| AbbVie(2 entities) | 75 | $778 |
| GSK | 30 | $351 |
| Astellas Pharma US Inc | 15 | $342 |
| Novo Nordisk | 20 | $297 |
| Amarin Pharma, Inc. | 20 | $274 |
| Lilly USA, LLC | 13 | $190 |
| Novartis | 11 | $184 |
| Boehringer Ingelheim | 10 | $164 |
| E.r. Squibb & Sons, L.L.C. | 4 | $162 |
| Pfizer | 9 | $144 |
| Avanir Pharmaceuticals, Inc. | 9 | $131 |
| Johnson & Johnson(2 entities) | 7 | $113 |
| Kowa Pharmaceuticals America, Inc. | 7 | $103 |
| Merck | 7 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $74 |
| Sunovion Pharmaceuticals Inc. | 3 | $61 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $58 |
| Supernus Pharmaceuticals, Inc. | 3 | $44 |
| Exact Sciences | 2 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $31 |
| Esperion Therapeutics, Inc. | 2 | $31 |
| Ironwood Pharmaceuticals, Inc | 2 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Smith+Nephew | 1 | $18 |
| Mylan Specialty L.p. | 1 | $17 |
| Organogenesis Inc. | 1 | $17 |
| Lucid Diagnostics Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Dexcom, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Circassia Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Abbott | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,053 in reported general payments places this provider in the 95th percentile of 22 adult medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 300 | $135,125 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 13 | $54,709 |
| FarxigaDapagliflozin Propanediol | 100 | $49,400 |
| JardianceEmpagliflozin | 64 | $44,813 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 75 | $39,720 |
| TrulicityDulaglutide | 22 | $30,189 |
| Invega SustennaPaliperidone Palmitate | 11 | $27,102 |
| JanuviaSitagliptin Phosphate | 53 | $22,082 |
| Breo ElliptaFluticasone/Vilanterol | 48 | $20,923 |
| OzempicSemaglutide | 20 | $18,701 |
| XareltoRivaroxaban | 25 | $18,656 |
| EntrestoSacubitril/Valsartan | 39 | $18,170 |
| Tresiba Flextouch U-100Insulin Degludec | 63 | $17,638 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 108 | $12,664 |
| TradjentaLinagliptin | 42 | $11,633 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $144 | $135,125300 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $351 | $66,740139 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $1,269 | $64,495132 claims |
| Boehringer IngelheimJardiance, Tradjenta | $164 | $56,446106 claims |
| Johnson & JohnsonInvega Sustenna, Xarelto | $113 | $45,75836 claims |
| Lilly USA, LLCTrulicity, Olanzapine | $190 | $34,378143 claims |
| MerckJanuvia, Dulera | $101 | $27,06470 claims |
| Novo NordiskOzempic | $297 | $18,70120 claims |
| NovartisEntresto | $184 | $18,17039 claims |
| AbbVieLinzess, Synthroid | $778 | $11,88383 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 22 adult medicine providers in Ohio.
Other adult medicine in London
- Angela GarlandCincinnati$4K
- Farzana TausifSylvania$3K
- Olusegun OdukoyaCleveland$2K
- Thomas SchmeiserTallmadge$823
- Charles KellerLogan$526
- Malini DesaiAkron$511
- Alexander CampoloNewark$505
- Tiffany SwainColumbus$448
- William SawyerCincinnati$443
- Malinda PowellLancaster$433
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.